Understanding social factors affecting care in liver cancer patients
Official title: Social Determinants of Health in Hepatobiliary Cancer Patients
Run by Mayo Clinic · NCT06053333 · Data updated 2026-11-12
This study looks at how social issues like travel, childcare, and job status affect Southeast Asian Americans with liver cancer and their ability to get care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | July 17, 2023 |
| Main results expected | July 17, 2028 |
| Study ends | July 17, 2028 |
| Registry record updated | February 4, 2026 |
| Trial ID | NCT06053333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been diagnosed with hepatobiliary cancers.
✕Probably not a fit
Patients under 18 years of age will not benefit from this study as they are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the social determinants of health that impact patients diagnosed with hepatobiliary cancer, particularly focusing on barriers to accessing care. It will assess factors such as travel limitations, childcare issues, unemployment, and education levels among Southeast Asian Americans. Participants will complete questionnaires and provide biological samples, while their medical records will be reviewed to gather comprehensive data on their health and social circumstances.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and interventions addressing the social barriers faced by hepatobiliary cancer patients, ultimately enhancing their access to care.
How similar studies have gone: While this study focuses on a specific population and set of social determinants, similar studies have shown success in identifying barriers to care in cancer patients, suggesting a potential for impactful findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18+ year of age with hepatobiliary cancers Exclusion Criteria: * Patients under 18 years of age
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Nguyen H. Tran, M.D. — Mayo Clinic in Rochester
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acceptance and Commitment Therapy to reduce cancer distress in hepatobiliary cancer patients
This project tests if Acceptance and Commitment Therapy (ACT) helps adults with hepatobiliary cancer reduce cancer-related distress.
-
Collecting blood samples to evaluate tests for early cancer detection
This study is collecting blood and tissue samples from people with and without cancer to see if new tests can help detect cancer earlier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.